The recent share market selloff has rattled investor confidence — but for those thinking long term, it could be a gift in disguise.
When share prices drop across the board, it often has less to do with company fundamentals and more to do with fear and uncertainty.
That creates opportunities to pick up high-quality ASX shares at better valuations, giving long-term investors a headstart on future gains.
Here are 10 ASX shares that analysts believe are buys right now:
CSL Ltd (ASX: CSL)
One of the ASX's true blue-chip healthcare giants, CSL has a strong defensive business with global scale. Its recent dip could be a great entry point for patient investors. The team at Goldman Sachs is bullish and has a buy rating and $318.40 price target on its shares.
Goodman Group (ASX: GMG)
One of the world's leading industrial property developers, Goodman continues to benefit from the structural shift toward e-commerce and data infrastructure. Its development pipeline and global reach make it a standout. Citi currently rates this ASX share as a buy with a $40.00 price target.
Lovisa Holdings Ltd (ASX: LOV)
This fast fashion jewellery retailer has a long runway for international expansion. With its shares down sharply, the risk-reward equation is firmly tilting back in favour of long-term investors. Bell Potter has a buy rating and $30.00 price target on the ASX share.
Macquarie Group Ltd (ASX: MQG)
Australia's global investment bank and asset manager has built an enviable track record. Despite short-term volatility, its long-term earnings power and diversification remain impressive. Morgan Stanley is a fan and has an overweight rating and $224.00 price target on its shares.
ResMed Inc. (ASX: RMD)
The world's leading CPAP manufacturer has been caught up in the tech and healthcare selloff, but the long-term growth story around sleep apnoea and respiratory health remains intact. Goldman Sachs has a conviction buy rating and $49.00 price target on its shares.
TechnologyOne Ltd (ASX: TNE)
One of the ASX's most consistently profitable tech businesses, with a sticky customer base and long runway for SaaS transition. It's rarely cheap — so recent weakness in the share price is always worth taking advantage of. UBS is likely to agree. It has a buy rating and $33.80 price target on its shares.
Telix Pharmaceuticals Ltd (ASX: TLX)
A rising star in the radiopharmaceutical space. Telix has commercial traction, a growing pipeline, and the kind of innovative edge that can lead to big outcomes if the pieces fall into place. Bell Potter is feeling bullish about its outlook. So much so, it has a buy rating and $36.00 price target on its shares.
WiseTech Global Ltd (ASX: WTC)
Down significantly from its highs, WiseTech is still a global leader in logistics software. Its CargoWise platform is used by some of the biggest freight companies in the world, and growth is expected to accelerate over the coming years. Goldman Sachs has a buy rating and $128.00 price target on the ASX shares.
Woolworths Group Ltd (ASX: WOW)
Defensive, dependable, and still growing. If you're after stability, recurring income, and solid returns, Woolworths offers an anchor in volatile times. Goldman Sachs is also a fan of the supermarket giant and has a buy rating and $36.10 price target on its shares.
Xero Ltd (ASX: XRO)
The cloud-based accounting software provider has become a go-to name for small businesses across the globe. With long-term growth potential still strong and margins expanding, Xero could be a smart buy after the recent weakness in tech stocks. Goldman Sachs certainly believes this is the case. It has a buy rating and $201.00 price target on the ASX share.
